- Home
- IXHL
as 04-01-2025 3:38pm EST
Stocks
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
| Founded: | 2001 | Country: | Australia |
| Employees: | N/A | City: | DOCKLANDS, VICTORIA |
| Market Cap: | 13.2M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 61.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.40 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.64 - $3.55 | Next Earning Date: | 05-14-2025 |
| Revenue: | $98,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 3817.05% | Revenue Growth (next year): | 66.67% |
Latest Incannex Healthcare Inc. News
IXHL Breaking Stock News: Dive into IXHL Ticker-Specific Updates for Smart Investing
GlobeNewswire
25 days ago
Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules
Newsfile
a month ago
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025
GlobeNewswire
2 months ago
Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates
GlobeNewswire
2 months ago
Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board
GlobeNewswire
2 months ago
Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea
Newsfile
4 months ago
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025
GlobeNewswire
5 months ago
Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
5 months ago
Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer
Compare IXHL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IXHL Incannex Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.